A research team at the University of Würzburg has gained new insights into the development of kidney tumors in young children. These enable a better risk assessment and could form the basis for ...
Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children's tumors and possibly opening up new ...
Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children's tumors and possibly opening up new ...
Genetically tailored treatment plans for children with a type of kidney cancer could help provide the most effective care while minimizing side effects as much as possible. Researchers at the Wellcome ...
Genetically tailored treatment plans for children with a type of kidney cancer could help provide the most effective care while minimizing side effects as much as possible. Researchers at the Wellcome ...
New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully ...
Childhood cancers are often considered genetically simple, containing few mutations. However, this notion has been challenged in a new study that found an unexpectedly high number of mutations in a ...
Wilms tumour is the most common paediatric renal malignancy, arising from disrupted nephrogenesis during fetal kidney development. Its pathobiology reflects a convergence of genetic mutations, ...
A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way ...
A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way ...
A research team at the Biocenter of Julius-Maximilians-Universität Würzburg (JMU), together with cooperation partners at the Wellcome Sanger Institute in Cambridge (UK), has taken a significant step ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results